ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >Retinoid Receptor agonists >Tamibarotene

Tamibarotene

Tamibarotene Structure
CAS No.
94497-51-5
Chemical Name:
Tamibarotene
Synonyms
AM80;C12864;Amnoid;CS-1151;Amnolake;NSC 608000;amibarotene;Tamibarotene;UNII-08V52GZ;Retinoid AM 80
CBNumber:
CB7426841
Molecular Formula:
C22H25NO3
Molecular Weight:
351.44
MOL File:
94497-51-5.mol
MSDS File:
SDS
Modify Date:
2023/6/30 15:45:59

Tamibarotene Properties

Melting point 231-232°C
Boiling point 449.6±45.0 °C(Predicted)
Density 1.154±0.06 g/cm3(Predicted)
RTECS DH6940000
storage temp. room temp
solubility Soluble to 50 mM in DMSO
form powder
pka 3.83±0.10(Predicted)
color white to off-white

SAFETY

Risk and Safety Statements

WGK Germany  3

Tamibarotene price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) T3205 Tamibarotene ≥98% (HPLC) 94497-51-5 5MG ₹10857.48 2022-06-14 Buy
Sigma-Aldrich(India) T3205 Tamibarotene ≥98% (HPLC) 94497-51-5 25MG ₹39771.05 2022-06-14 Buy
Product number Packaging Price Buy
T3205 5MG ₹10857.48 Buy
T3205 25MG ₹39771.05 Buy

Tamibarotene Chemical Properties,Uses,Production

Description

Tamibarotene, a selective agonist of the retinoic acid receptor, was launched in Japan as an oral treatment for relapsed or refractory acute promyelocytic leukemia (APL). APL is a form of acute myeloid leukemia (AML) characterized by a deficiency in mature blood cells and an excess of immature cells called promyelocytes in the bone marrow and peripheral blood. The current standard of care for APL includes treatment with all-trans-retinoic acid (ATRA), either alone or in combination with chemotherapy. ATRA is a high affinity ligand for two types of nuclear receptors, retinoic acid receptor (RAR) and retinoid X receptor (RXR), each of which has three subtypes (-α, -β, and -γ). Activation of RARα by ATRA causes promyelocytes to differentiate and mature, thereby inhibiting their proliferation and inducing disease remission. Although ATRA is one of the most clinically successful retinoids, its usage is hampered by the high rate of adverse effects, instability, and the appearance of ATRA-resistant leukemia cells.Adverse events included retinoic acid syndrome, hyperleukocytosis, xerosis, cheilitis, hypertriglyceridemia, and hypercholesterolemia; however, these side effects were generally milder than with ATRA, which all patients had received previously. Examination of human samples taken from Phase II and III clinical trials revealed that fecal excretion was the major elimination route, and the metabolism of tamibarotene occurred primarily through hydroxylation and taurine conjugation. In vitro, the plasma protein binding of tamibarotene is shown to be >98% in rats, dogs, and humans. Tamibarotene is synthesized from 5,5,8,8-tetramethyl-5,6,7, 8-tetrahydronaphthalene in a four-step sequence consisting of regioselective nitration in the 2-position, reduction of the nitro group by hydrogenation to produce the corresponding aniline derivative, acylation of the aniline intermediate with 4-(carbomethoxy)benzoyl chloride, and hydrolysis of the methyl ester.

Chemical Properties

Crystalline Solid

Uses

Tamibarotene, a retinoic acid receptor-α(RARα) agonist, was approved for the treatment of relapsed or refractory acute promyelocytic leukemia (APL) in Japan on June, 2005 and is currently marketed by Nippon Shinyaku Co. This novel drug has shown high remission rate among patients who have recurrent disease after all trans retinoic acid therapy.

Definition

ChEBI: A dicarboxylic acid monoamide resulting from the condensation of one of the carboxy groups of terephthalic acid with the amino group of 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine.

Biological Activity

Retinoic acid receptor α (RAR α ) agonist that induces differentiation (ED 50 = 0.79 nM) and apoptosis of HL-60 cells in vitro . Exhibits antiproliferative effects against a variety of human tumor cells lines (mean values of 35, 40 and 60% growth inhibition at 0.1, 1 and 10 μ M respectively) and displays anticancer activity against acute promyelocytic leukemia in vivo .

Tamibarotene Preparation Products And Raw materials

Global( 202)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Archerchem Healthcare Pvt., Ltd. (part of Archerchem Group) 91-22-42361111 Maharashtra, India 147 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Clearsynth Labs 91-22-45045900 Maharashtra, India 3889 58 Inquiry
Grr Fine Chem/Grr Exports 91-79-40031771 Gujarat, India 405 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21676 55 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry

Tamibarotene Spectrum

AM80 Tamibarotene 4-[(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino]carbonyl]benzoic Acid Am 80 (pharmaceutical) Amnolake NSC 608000 Retinoid AM 80 4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-ylaminocarbonyl)benzoic acid 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen)-2-yl]aminocarbonyl]benzoic acid 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen-2-yl)amino]carbonyl]benzoic acid C12864 4-[(5,5,8,8-tetraMethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbaMoyl]benzoic acid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetraMethyl-2-naphthalenyl)carbaMoyl]benzoic acid, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetraMethyl-2-naphthyl)carbaMoyl] benzoic acid TAMIBAROTENE,AM 80, AM-80, AM80 4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoicacid -((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl)benzoic acid Amnoid N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl)-2-naphthyl)terephthalamic acid N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)terephthalamic acid UNII-08V52GZ Tamibarotene, >=99% Tamibarotene(Am-80) AM80; AM 80; AM-80 CS-1151 Benzoic acid, 4-[[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino]carbonyl]- Tamibarotene USP/EP/BP Butanoicacid,9-methoxy- amibarotene Oteseconazole Impurity 5 NSC 608000|||Am 80|||Amnolake 94497-51-5 Inhibitors Intermediates & Fine Chemicals Pharmaceuticals Retinoids